Conference Description:
The best forum to gain applied and basic knowledge, build your collaborative network, and learn skills to move your projects forward in one of today's hottest research areas
AsiaTIDES continues to be the premier forum to get a comprehensive update, meet key players and increase your knowledge of the oligonucleotide- and peptide-based therapeutics fields.
The faculty list for the 2012 program is the strongest yet, with more representation from big pharma than ever before. Hear new data and strategic perspectives from Merck, Genzyme, and GlaxoSmithKline, including three presentations from Glaxo on a peptide project and their assessments of both the oligo and peptide landscape. Plus hear from Isis, Novo Nordisk, Ipsen, Quark, Alnylam, Santaris, Tekmira and a host of other important companies you need to follow to stay abreast of this field.
•Regulatory Updates: Preclinical Safety Assessment of Oligonucleotides and Peptides including Reports from JPMA and the Oligonucleotide Safety Working Group on ICH S6 and Off Target Effects
•miRNA, Oligonucleotides, Peptides and Peptide Vaccines: Updates on therapeutic candidates in preclinical and clinical development
•Manufacturing and analytical development strategies to speed process development
•Formulation and delivery updates to help you gauge product marketability
In-Depth Tutorials to Increase your Knowledge:
•Technical and Regulatory Aspects of Peptide Specifications and Characterization: From Preclinical through to Market Application
•Strategies and Approaches for in vivo Delivery of Oligonucleotides
Past attendees congratulate AsiaTIDES
"The TIDES series of conferences is an indispensable catalyst for the industry, bringing expert people together to share their knowledge and address common issues, ensuring that we can grow our respective enterprises and help TIDES-based medicine flourish. A unique opportunity to hear the latest developments in the field across all disciplines and hear how industry colleagues are rising to the challenges. Over and above the informative presentations will be the invaluable networking with experienced and knowledgeable individuals."
- Prosensa Therapeutics, The Netherlands
Start Date: 2012-02-28
Last Day: 2012-03-01
Contact Person: Rita Parasurum
Email: rita.parasurum@ibcasia.com.sg
Address:
Sheraton Miyako Tokyo, Tokyo, Japan
;)
